155 related articles for article (PubMed ID: 12599340)
1. Kava: a supplement to avoid.
Consum Rep; 2003 Mar; 68(3):8. PubMed ID: 12599340
[No Abstract] [Full Text] [Related]
2. Dangerous supplements: still at large.
Consum Rep; 2004 May; 69(5):12-7. PubMed ID: 15104077
[No Abstract] [Full Text] [Related]
3. Risky pills: supplements to avoid.
Consum Rep; 2008 Jan; 73(1):46-7. PubMed ID: 18488285
[No Abstract] [Full Text] [Related]
4. Regulating dietary supplement safety under the dietary supplement health and education act: brave new world or pyrrhic victory?
Silverglade BA
Food Drug Law J; 1996; 51(2):319-21. PubMed ID: 11822324
[No Abstract] [Full Text] [Related]
5. Natural-born killers.
Mandavilli A
Nat Med; 2003 Jun; 9(6):634-5. PubMed ID: 12778149
[No Abstract] [Full Text] [Related]
6. Re-thinking the dietary supplement laws and regulations 14 years after the Dietary Supplement Health and Education Act implementation.
Jiang T
Int J Food Sci Nutr; 2009 Jun; 60(4):293-301. PubMed ID: 19085198
[TBL] [Abstract][Full Text] [Related]
7. Ephedra: yesterday, DSHEA, and tomorrow--a ten year perspective on the Dietary Supplement Health and Education Act of 1994.
Seamon MJ; Clauson KA
J Herb Pharmacother; 2005; 5(3):67-86. PubMed ID: 16520299
[TBL] [Abstract][Full Text] [Related]
8. From herbal Prozac to Mark McGwire's tonic: how the Dietary Supplement Health and Education Act changed the regulatory landscape for health products.
Kaczka KA
J Contemp Health Law Policy; 2000; 16(2):463-99. PubMed ID: 10970182
[No Abstract] [Full Text] [Related]
9. Protecting consumers in the wake of the U.S. Dietary Supplement Health and Education Act.
Foote JC
J Allied Health; 2007; 36(1):57-60. PubMed ID: 17425193
[TBL] [Abstract][Full Text] [Related]
10. Risk of kava hepatotoxicity and the FDA consumer advisory.
Teschke R; Schulze J
JAMA; 2010 Nov; 304(19):2174-5. PubMed ID: 21081732
[No Abstract] [Full Text] [Related]
11. Kava concerns. FDA, Botanical Council raises safety concerns.
AWHONN Lifelines; 2002; 6(1):13-5. PubMed ID: 11971236
[No Abstract] [Full Text] [Related]
12. Another FDA warning: Kava supplements.
Parkman CA
Case Manager; 2002; 13(4):26-8. PubMed ID: 12131903
[No Abstract] [Full Text] [Related]
13. Dangerous supplements: what you don't know about these 12 ingredients could hurt you.
Consum Rep; 2010 Sep; 75(9):16-20. PubMed ID: 20712098
[No Abstract] [Full Text] [Related]
14. Hepatic toxicity possibly associated with kava-containing products--United States, Germany, and Switzerland, 1999-2002.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2002 Nov; 51(47):1065-7. PubMed ID: 12500906
[TBL] [Abstract][Full Text] [Related]
15. Ephedra: heart dangers in disguise.
Consum Rep; 2004 Jan; 69(1):22-3. PubMed ID: 14677546
[No Abstract] [Full Text] [Related]
16. What makes consumers think dietary supplements are safe and effective? The role of disclaimers and FDA approval.
Dodge T; Kaufman A
Health Psychol; 2007 Jul; 26(4):513-7. PubMed ID: 17605572
[TBL] [Abstract][Full Text] [Related]
17. Regulation of dietary supplement advertising: current claims of interest to the Federal Trade Commission, Food and Drug Administration and National Advertising Division.
Villafranco JE; Lustigman AB
Food Drug Law J; 2007; 62(4):709-25. PubMed ID: 18557227
[No Abstract] [Full Text] [Related]
18. The curious case of Kava.
Grossman L
Time; 2002 Apr; 159(14):58. PubMed ID: 11951318
[No Abstract] [Full Text] [Related]
19. Working to get ephedra banned.
Consum Rep; 2003 Feb; 68(2):6. PubMed ID: 12516584
[No Abstract] [Full Text] [Related]
20. Disclaimers in dietary supplement print advertising: the bodybuilding category as a model case for change.
Soller RW; Rice LG; Ambrose PJ
Food Drug Law J; 2007; 62(2):375-86. PubMed ID: 17632967
[No Abstract] [Full Text] [Related]
[Next] [New Search]
